ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 727087 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 727087; 2) Community: the network communities that were significantly associated with the response to NSC 727087; 3) Molecule: the relationships between components within communities and NSC 727087; 4) MDR: the compounds that were significantly associated with the NSC 727087.

NSC Compound Enrichment Correlation
NSC 339137 PHYSALOLACTONE 0.0385613993886001 0.27728674
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0385613993886001 0.1645895
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0385613993886001 0.20502084
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0385613993886001 0.36465942
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0385613993886001 0.18266027
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0385613993886001 0.34540599
NSC 45236 Null 0.0385613993886001 0.21751966
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0385613993886001 0.21323094
NSC 604976 Verrucarin A, 7'-deoxo-2'-deoxy-2',3'-epoxy-8',9',10',11'- tetrahydro-4',8-dihydroxy-7'-(1-hydroxyethyl)- 0.0385613993886001 0.048940073
NSC 606497 Camptothecin Derivative 0.0385613993886001 0.1084559
Total:144  Current:101    [First] [Prev] [Next] [Last]